Treace Medical Concepts, Inc. (TMCI) Return on equity 2019–2025
Treace Medical Concepts, Inc. (TMCI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-67.6%FY2025 · since FY2019: -134.9% → -67.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -67.6% | -18.2 pp |
| FY2024 | -49.4% | -13.5 pp |
| FY2023 | -35.9% | +34.8 pp |
| FY2022 | -70.7% | -48.7 pp |
| FY2021 | -22.1% | +450.6 pp |
| FY2020 | -472.7% | -337.8 pp |
| FY2019 | -134.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More TMCI financial trends
TMCI RevenueTMCI Net incomeTMCI Net marginTMCI Gross profitTMCI Gross marginTMCI Operating incomeTMCI Operating marginTMCI Operating cash flowTMCI Free cash flowTMCI Capital expendituresTMCI Stock buybacksTMCI Dividends paidTMCI Total assetsTMCI Total liabilitiesTMCI Shareholders’ equityTMCI overview →